ADELAIDE, AUSTRALIA: Australian medical technology company LBT Innovations Limited (ASX: LBT) has been engaged by AstraZeneca for the full product development for its APAS Pharma product. LBT Innovations has been engaged by AstraZeneca, a global biopharmaceutical company, to undertake a full product development project for the Company’s new APAS® Pharma analysis module (artificial intelligence software)…